FDA Approved: THIOLA EC — Supplemental Application (Mission Pharmacal Company)

View source ↗

Summary

FDA approved a supplemental application for THIOLA EC (tiopronin) from Mission Pharmacal Company, adding the extended-release formulation to the product lineup.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinuria
• Nephrolithiasis

Drugs mentioned

• THIOLA EC (tiopronin)

Snippet

SUPPL AP for THIOLA EC (TIOPRONIN)